Table 1.
HCV Genotype Distribution and Other Factors
| Prevalence of HCV Genotypes (%)
|
||||
|---|---|---|---|---|
| Factor (No. of Subjects) | 6a | 3a | 3b | 1a or 1b |
| Gender | ||||
| Male (29) | 13 (44.8) | 1 (3.4) | 9 (31.1) | 6 (20.7) |
| Female (33) | 18 (54.5) | 1 (3.1) | 11 (33.3) | 3 (9.1) |
| Age (Year) | ||||
| ≤ 30 (22) | 12 (54.5) | 1 (4.5) | 5 (22.7) | 4 (18.3) |
| 31–40 (22) | 9 (40.9) | 1 (4.5) | 11 (50.1) | 1 (4.5) |
| > 40 (18) | 10 (55.6) | 0 (0.0) | 4 (22.2) | 4 (22.2) |
| Years of Injection Drug Use | ||||
| ≤ 2 (10) | 6 (60.0) | 0 (0.0) | 3 (30.0) | 1 (10.0) |
| > 2 (52) | 25 (48.1) | 2 (3.9) | 17(32.7) | 8 (15.3) |
| Needle Sharing | ||||
| Yes (23) | 11 (47.8) | 0 (0.0) | 8 (34.8) | 4 (17.4) |
| No (39) | 20 (51.3) | 2 (5.2) | 12 (30.7) | 5 (12.8) |
Derived from χ2 tests of association or Fisher’s exact tests comparing HCV genotypes within the risk factors, P > 0.05.